Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) is a neurodegenerative disorder associated with extracellular amyloid-β peptide deposition and progressive neuron loss. Strong evidence supports that neuroinflammatory changes such as the activation of astrocytes and microglia cells are important in the disease p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Res Ther
Autores principales: Aichholzer, Freyja, Klafki, Hans-Wolfgang, Ogorek, Isabella, Vogelgsang, Jonathan, Wiltfang, Jens, Scherbaum, Norbert, Weggen, Sascha, Wirths, Oliver
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8097817/
https://ncbi.nlm.nih.gov/pubmed/33947460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-021-00828-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares